Progastrin Promotes Colorectal Cancer Stem Cell‐Like Properties via the Receptor PZR

The tumor microenvironment promotes cancer progression in part by supporting cancer stem cells (CSC). In colorectal cancer (CRC), progastrin (PG), an orphan growth factor secreted by tumor cells within the tumor and its microenvironment, maintains CSCs by unidentified mechanisms. Here, the orphan receptor Protein Zero-Related protein (PZR) is identified as an essential component of PG activity and demonstrated its utility as a therapeutic target. PZR is essential for growth of PG-expressing tumors, while genetic inactivation in mice of Mpzl1, which encodes PZR, disrupted chemically-induced colon transformation. Mechanistically, PG binds cellular glycosylated and dimeric PZR and promotes SHP2/SRC/β-catenin-dependent CSC-like signaling. Blocking PZR by monoclonal antibodies inhibited PG-dependent expansion of tumoroids derived from murine intestinal tumors and patient-derived CRC cell lines, while in mice, it reduced adenoma formation triggered by Apc loss in stem cells and disrupted the tumor-initiating capacity of PG-expressing CRC cells. High GAST (which encodes PG) and MPZL1 transcript levels in primary colon cancer patients is predictive of worse prognosis. Collectively, these findings support the inhibition of PZR as a potential targeted treatment of PG-expressing CRC.

Authors

Institutions

Publication Details

Journal
Advanced Science
Published
2025-08-03
DOI
https://doi.org/10.1002/advs.202502136
Citations
2
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Progastrin Promotes Colorectal Cancer Stem Cell‐Like Properties via the Receptor PZR

Michael Hahne, M. Lafitte, Romain M. Larive, Lucile Bansard et al.
2 citations
Advanced Science
Cancer Cells and Metastasis
2.09
article

Progastrin Promotes Colorectal Cancer Stem Cell‐Like Properties via the Receptor PZR

Michael Hahne, M. Lafitte, Romain M. Larive, Lucile Bansard, Jacques Colinge, Audrey Sirvent, Maya Jeitany, Valérie Simon, Maud Maillard, Maud Barbery, Steeve Thirard, Kevin Espie, Pierre Martineau, Elise Fourgous, Julie Pannequin, Yvan Boublik, Serge Roche, Nathalie Coutry, Madeline Neiveyans, Jihane Vitre, Julie Nguyen, Conception Paul, Philippe Jay
article en
2 citations

Abstract

The tumor microenvironment promotes cancer progression in part by supporting cancer stem cells (CSC). In colorectal cancer (CRC), progastrin (PG), an orphan growth factor secreted by tumor cells within the tumor and its microenvironment, maintains CSCs by unidentified mechanisms. Here, the orphan receptor Protein Zero-Related protein (PZR) is identified as an essential component of PG activity and demonstrated its utility as a therapeutic target. PZR is essential for growth of PG-expressing tumors, while genetic inactivation in mice of Mpzl1, which encodes PZR, disrupted chemically-induced colon transformation. Mechanistically, PG binds cellular glycosylated and dimeric PZR and promotes SHP2/SRC/β-catenin-dependent CSC-like signaling. Blocking PZR by monoclonal antibodies inhibited PG-dependent expansion of tumoroids derived from murine intestinal tumors and patient-derived CRC cell lines, while in mice, it reduced adenoma formation triggered by Apc loss in stem cells and disrupted the tumor-initiating capacity of PG-expressing CRC cells. High GAST (which encodes PG) and MPZL1 transcript levels in primary colon cancer patients is predictive of worse prognosis. Collectively, these findings support the inhibition of PZR as a potential targeted treatment of PG-expressing CRC.

Advanced ScienceVol. 12(38)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université de Montpellier (FR), Laboratoire d'Informatique, de Robotique et de Microélectronique de Montpellier (FR), Institut de Génétique Moléculaire de Montpellier (FR), Géosciences Montpellier (FR), Institute for Neurosciences of Montpellier (FR), Institut de Recherche en Cancérologie de Montpellier (FR)
Fondation pour la Recherche Médicale
Good health and well-being
Openalex Percentile: Top 11%
Cancer Cells and Metastasis
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.